Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Sun Pharma Arranges $4 Billion Loan to Refinance Organon Acquisition Bridge Financing

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Sun Pharma Arranges $4 Billion Loan to Refinance Organon Acquisition Bridge Financing

Analysed 16 Nov 2026·2 sources analysed·Mumbai, India·Business
Sun Pharma Arranges $4 Billion Loan to Refinance Organon Acquisition Bridge FinancingPreviousNext

Sun Pharmaceutical Industries plans to secure a $4 billion syndicated loan to refinance part of the bridge financing used for its $11.75 billion acquisition of US healthcare company Organon Co. Five lead arrangers—Citibank, MUFG, Standard Chartered Bank, BNP Paribas, and DBS Bank—are finalizing terms for a five-year facility with a margin of 110-120 basis points over the Secured Overnight Financing Rate. Additional lenders may join, and Sun Pharma is also considering other funding options like non-convertible debentures, equity, and dollar bonds.

Sentiment
52%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 50/100.

Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 16 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (52/100)

Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

economictimes broke this story on 15 Nov, 06:59 pm. Other outlets followed.

15 Nov, 06:59 pm2 sources · 7 h16 Nov, 01:37 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Indian Companies Report Mixed Quarterly Results and Corporate Developments on November 16
Next →
Corporate India Reports 26% Profit Growth with Strongest Revenue Rise in 16 Quarters
1
economictimes15 Nov, 06:59 pm
Sun Pharma eyes 4 billion loan for Organon buy, five banks likely to anchor refinancing
  • 2
    economictimes16 Nov, 01:37 am
    Sun Pharma eyes 4 billion loan for Organon buy, five banks likely to anchor refinancing
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Organon CoStandard Chartered BankBanque Nationale de Paris ParibasDevelopment Bank of SingaporeSun Pharmaceutical IndustriesState Bank of IndiaMitsubishi UFJ Financial GroupCitibank

    Story context

    Category
    Business
    Location
    Mumbai, India
    Sources analysed
    2
    Last analysed
    16 Nov 2026
    Key entities
    Sun PharmaBridge loanSyndicated loanRefinancingSOFROrganonBroadcast syndicationOrganon & Co.Mitsubishi UFJ Financial GroupBNP ParibasOil refineryMumbai